1. Home
  2. DYAI

as of 12-08-2025 12:10pm EST

$0.98
+$0.03
+3.16%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Chart Type:
Time Range:
Founded: 1979 Country:
United States
United States
Employees: N/A City: JUPITER
Market Cap: 30.2M IPO Year: 2004
Target Price: $3.00 AVG Volume (30 days): 540.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.22 EPS Growth: N/A
52 Week Low/High: $0.71 - $2.20 Next Earning Date: 11-12-2025
Revenue: $3,342,195 Revenue Growth: -0.66%
Revenue Growth (this year): 12.52% Revenue Growth (next year): 92.04%

AI-Powered DYAI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 20 hours ago

AI Recommendation

hold
Model Accuracy: 69.18%
69.18%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Dyadic International Inc. News

DYAI Breaking Stock News: Dive into DYAI Ticker-Specific Updates for Smart Investing

All DYAI News

Share on Social Networks: